RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 100 filers reported holding RHYTHM PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | +488.2% | 5,992 | -26.5% | 0.00% | – |
| Q2 2022 | $34,000 | -63.8% | 8,155 | 0.0% | 0.00% | – |
| Q1 2022 | $94,000 | +16.0% | 8,155 | 0.0% | 0.00% | – |
| Q4 2021 | $81,000 | -19.0% | 8,155 | +6.0% | 0.00% | – |
| Q3 2021 | $100,000 | +163.2% | 7,691 | +298.5% | 0.00% | – |
| Q2 2021 | $38,000 | +280.0% | 1,930 | +313.3% | 0.00% | – |
| Q1 2021 | $10,000 | -50.0% | 467 | -32.2% | 0.00% | – |
| Q4 2020 | $20,000 | +33.3% | 689 | 0.0% | 0.00% | – |
| Q3 2020 | $15,000 | 0.0% | 689 | 0.0% | 0.00% | – |
| Q2 2020 | $15,000 | +66.7% | 689 | +129.7% | 0.00% | – |
| Q4 2017 | $9,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |